Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brigid Reynolds, NP
Georgetown University
Principal Investigator - Jacobo Mintzer, MD
Ralph H. Johnson Veterans Affairs Medical Center (VAMC)
Principal Investigator - Paul Aisen, MD
Alzheimer's Therapeutic Research Institute
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georgetown University
Washington D.C., District of Columbia, United States
- Howard University
Washington D.C., District of Columbia, United States
- Melgar-Caro Medcenter and Community Research (mcmcr)
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
- University of Kentucky
Lexington, Kentucky, United States
- Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
- University of Maryland
Baltimore, Maryland, United States
- Case Western Reserve University
Beachwood, Ohio, United States
- Ralph H. Johnson Va Medical Center
Charleston, South Carolina, United States
- Vanderbilt University Medical Center Center for Cognitive Medicine
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2023
- Primary completion
- 30 Apr 2026
- Completion
- 1 Aug 2026
- Last update posted
- 4 May 2026
- Registered enrollment
- 120
- Registry id
- NCT05644262
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.